MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G Report for Taysha Gene Therapies, Inc. Common Stock (TSHA)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Taysha Gene Therapies, Inc. Common Stock
Symbol
TSHA
Shares outstanding
204,991,442 shares
Disclosed Ownership
17,629,264 shares
Ownership
8.6%
Form type
SCHEDULE 13G
Filing time
05 Feb 2025, 10:43:37 UTC
Date of event
31 Dec 2024
Next filing
06 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 8.6% 17,629,264 0 17,442,037 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 7% 14,375,830 0 14,375,830 Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC